Publication | Open Access

Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effects

Intravenous InfusionOncologyNon-small-cell Lung CancerImmunomodulatory EffectsMedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorImmunotherapyPharmacologyCell TransplantationLung CancerCancer Research